Aspirin-Induced Delayed Urticaria in Children with Kawasaki Disease: A Retrospective Case-Control Study

References

• Dietz SM, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr. 2017;176(8):995–1009. doi:10.1007/s00431-017-2937-5
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e999. doi:10.1161/CIR.0000000000000484
   PubMed Web of Science ®Google Scholar
• Huang PY, Huang YH, Guo MM, Chang LS, Kuo HC. Kawasaki disease and allergic diseases. Front Pediatr. 2021;8:614386. doi:10.3389/fped.2020.614386
   PubMed Web of Science ®Google Scholar
• Dallaire F, Fortier-Morissette Z, Blais S, et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease. Pediatrics. 2017;139(6):e20170098. doi:10.1542/peds.2017-0098
   PubMed Web of Science ®Google Scholar
• Platt B, Belarski E, Manaloor J, et al. Comparison of risk of recrudescent fever in children with Kawasaki disease treated with intravenous immunoglobulin and low-dose vs high-dose aspirin. JAMA Netw Open. 2020;3(1):e1918565. doi:10.1001/jamanetworkopen.2019.18565
   PubMed Web of Science ®Google Scholar
• Modena B, White AA, Woessner KM. Aspirin and nonsteroidal antiinflammatory drugs hypersensitivity and management. Immunol Allergy Clin North Am. 2017;37(4):727–749.
   PubMed Web of Science ®Google Scholar
• Laidlaw TM, Cahill KN. Current knowledge and management of hypersensitivity to aspirin and NSAIDs. J Allergy Clin Immunol Pract. 2017;5(3):537–545. doi:10.1016/j.jaip.2016.10.021
   PubMed Web of Science ®Google Scholar
• Mourad AA, Bahna SL. Hypersensitivities to non-steroidal anti-inflammatory drugs. Expert Rev Clin Immunol. 2014;10(9):1263–1268. doi:10.1586/1744666X.2014.946905
   PubMed Web of Science ®Google Scholar
• Cavkaytar O, Arik Yilmaz E, Buyuktiryaki B, Sekerel BE, Sackesen C, Soyer OU. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria. Allergy. 2015;70(2):153–160. doi:10.1111/all.12539
   PubMed Web of Science ®Google Scholar
• Kidon MI, Kang LW, Chin CW, et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics. 2005;116(5):e675–e680. doi:10.1542/peds.2005-0969
   PubMed Web of Science ®Google Scholar
• Wedi B, Kapp A. Aspirin induced adverse skin reactions: new pathophysiological aspects. Thorax. 2000;55(Suppl 2):S70–S71. doi:10.1136/thorax.55.suppl_2.S70
   PubMed Web of Science ®Google Scholar
• Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003;28(2):123–127. doi:10.1046/j.1365-2230.2003.01228.x
   PubMed Web of Science ®Google Scholar
• Higashi N, Taniguchi M, Mita H, Higashi A, Akiyama K. Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma. J Allergy Clin Immunol. 2002;110(4):666–667. doi:10.1067/mai.2002.128016
   PubMed Web of Science ®Google Scholar
• Cavkaytar O, Du Toit G, Caimmi D. Characteristics of NSAID-induced hypersensitivity reactions in childhood. Pediatr Allergy Immunol. 2019;30:25–35. doi:10.1111/pai.12980
   PubMed Web of Science ®Google Scholar
• Patel RM, Marfatia YS. Clinical study of cutaneous drug eruptions in 200 patients. Indian J Dermatol Venereol Leprol. 2008;74:430. doi:10.4103/0378-6323.42883
   PubMed Web of Science ®Google Scholar
• Gebhardt M, Wollina U. Cutaneous side-effects of nonsteroidal anti-inflammatory drugs (NSAID). Z Rheumatol. 1995;54:405–412.
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Makowska JS. Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res. 2015;7:312–320. doi:10.4168/aair.2015.7.4.312
   PubMed Web of Science ®Google Scholar
• Kawakami T, Fujita A, Takeuchi S, Muto S, Soma Y. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. J Am Acad Dermatol. 2009;60(1):146–149. doi:10.1016/j.jaad.2008.07.044
   PubMed Web of Science ®Google Scholar
• Dionne A, Dahdah N. A decade of NT-proBNP in acute Kawasaki disease, from physiological response to clinical relevance. Children (Basel). 2018;5(10):E141. doi:10.3390/children5100141
   PubMed Web of Science ®Google Scholar
• Lin KH, Chang SS, Yu CW, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open. 2015;5(4):e006703. doi:10.1136/bmjopen-2014-006703
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 2013;68:1219–1232. doi:10.1111/all.12260
   PubMed Web of Science ®Google Scholar
• Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet. 1997;350(9091):1599–1600. doi:10.1016/S0140-6736(05)64015-9
   PubMed Web of Science ®Google Scholar
• Sánchez-Borges M, Acevedo N, Vergara C, et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol. 2009;19:375–382.
   PubMed Web of Science ®Google Scholar
• Zhang H, Shi L, Li XH, et al. Gene polymorphism of aspirin-induced urticaria in children with Kawasaki disease. Front Pediatr. 2019;7:505. doi:10.3389/fped.2019.00505
   PubMed Web of Science ®Google Scholar
• Choi JH, Kim SH, Bae JS, et al. Lack of an association between a newly identifi ed promoter polymorphism (−1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population. Tohoku J Exp Med. 2006;208:49–56. doi:10.1620/tjem.208.49
   PubMed Web of Science ®Google Scholar
• Van Sambeek R, Stevenson DD, Baldasaro M, et al. 5ʹ flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol. 2000;106:72–76. doi:10.1067/mai.2000.107603
   PubMed Web of Science ®Google Scholar